JP2012140384A - Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same - Google Patents

Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same Download PDF

Info

Publication number
JP2012140384A
JP2012140384A JP2011000910A JP2011000910A JP2012140384A JP 2012140384 A JP2012140384 A JP 2012140384A JP 2011000910 A JP2011000910 A JP 2011000910A JP 2011000910 A JP2011000910 A JP 2011000910A JP 2012140384 A JP2012140384 A JP 2012140384A
Authority
JP
Japan
Prior art keywords
drug
container
screen door
carrier
room temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011000910A
Other languages
Japanese (ja)
Inventor
Seiichi Kajima
誠一 鹿島
Ryoko Ukita
涼子 浮田
Yukio Kikuta
幸雄 菊田
Ayumi Hagiwara
亜由美 萩原
Yumi Kawajiri
由美 川尻
Koji Nakayama
幸治 中山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainihon Jochugiku Co Ltd
Original Assignee
Dainihon Jochugiku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainihon Jochugiku Co Ltd filed Critical Dainihon Jochugiku Co Ltd
Priority to JP2011000910A priority Critical patent/JP2012140384A/en
Publication of JP2012140384A publication Critical patent/JP2012140384A/en
Pending legal-status Critical Current

Links

Landscapes

  • Catching Or Destruction (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a drug sublimating object in which a carrier containing room temperature sublimating drug is housed inside of a flat shaped drug container used by fixing the same to a screen door, which does not hinder a window or a weather door even though fixed to the screen door, and in which drug effectively sublimates and spreads over the whole screen door, and which can repel or evade the flying harmful insects such as mosquitos and black flies and a method for repelling the flying harmful insects using the same.SOLUTION: In the drug sublimating object in which the carrier containing room temperature sublimating drug is housed inside of the flat shaped drug container, the thickness of the drug container is 3 mm to 10 mm, and a gap of not less than 1 mm is arranged between the carrier and an inner face of the drug container.

Description

本発明は、蚊、ブユ等の飛翔害虫を駆除又は忌避するために、網戸に固定して、常温揮散性薬剤を効率的に揮散させる薬剤揮散体及びこれを用いた飛翔害虫防除方法に関するものである。 TECHNICAL FIELD The present invention relates to a chemical volatilizer that efficiently fixes a room temperature volatile chemical by fixing it to a screen door to eliminate or repel flying insect pests such as mosquitoes and flyfish, and a method for controlling flying insects using the same. is there.

従来から常温揮散性薬剤を空気中に揮散させることによって、飛翔害虫の駆除や忌避を行う防除剤は知られており、例えば特許文献1(特開2001−200239号公報)に記載の防除剤が開示されている。また、使用期間中に薬剤を安定して揮散させるため、ポリエチレン等のポリオレフィン系樹脂に薬剤を練り込んだ担体を用いた薬剤揮散体が開発され、例えば特許文献2(特開2001−279033号公報)に記載の薬剤揮散体が開示されている。更に、常温揮散性薬剤を含有する担体をコンパクトな薬剤容器の内部に収納し、通常の室温で吊り下げ又は置いて使用する薬剤揮散体が開示されている(特開2008−194034号公報)。 Conventionally, there is known a control agent for controlling and repelling flying insects by volatilizing a room temperature volatile chemical into the air. For example, a control agent described in Patent Document 1 (Japanese Patent Application Laid-Open No. 2001-200299) is known. It is disclosed. In addition, in order to stably volatilize the drug during the period of use, a drug volatilization body using a carrier in which the drug is kneaded into a polyolefin resin such as polyethylene has been developed. For example, Patent Document 2 (JP 2001-279033 A) ) Is disclosed. Furthermore, a drug volatilizer is disclosed in which a carrier containing a room temperature volatile drug is housed in a compact drug container and hung or placed at a normal room temperature (Japanese Patent Laid-Open No. 2008-194034).

これらの文献によれば、常温揮散性薬剤を空気中に揮散させることによって、飛翔害虫の駆除や忌避を行うことができる。しかしながら、特許文献1に記載の薬剤揮散体は、薬剤を含浸したネット状物を複数枚層状に重ね、送風装置を用いて薬剤を揮散させる方法であり、また、特許文献2では、薬剤を樹脂に練り込んだタイプの薬剤揮散体において、構造上、薬剤を含浸させたタイプの薬剤揮散体に比べて揮散制御が可能であることが開示されているが、一部の形状が示されるのみであり、長期的にどのように安定した揮散性能を実現するかについては開示されていない。更に特許文献3には、吊るしたり置いたりする薬剤揮散体について開示されているが、本発明の網戸に固定して飛翔害虫を駆除又は忌避する方法は開示されていない。 According to these documents, the flying pests can be controlled and repelled by volatilizing the room temperature volatile chemical in the air. However, the chemical volatilizer described in Patent Document 1 is a method in which a plurality of nets impregnated with a chemical are stacked in layers, and the chemical is volatilized using a blower. It is disclosed that the volatilization control is possible compared to the chemical volatilization type impregnated with the chemical in the chemical volatilization type kneaded in, but only a part of the shape is shown. There is no disclosure of how to achieve stable volatilization performance over the long term. Further, Patent Document 3 discloses a chemical volatilization body that is hung or placed, but does not disclose a method for exterminating or repelling flying insects by fixing to a screen door of the present invention.

特開2001−200239号公報Japanese Patent Laid-Open No. 2001-200299 特開2001−279033号公報JP 2001-279033 A 特開2008−194034号公報JP 2008-194034 A

本発明は、常温揮散性薬剤を含有する担体を扁平状の薬剤容器の内部に収納し、網戸に固定して用いる薬剤揮散体であって、網戸に固定しても窓や雨戸の邪魔にならず、かつ薬剤が効率的に揮散し、網戸全体に広がり、蚊、ブユ等の飛翔害虫を駆除又は忌避することが可能な薬剤揮散体及びこれを用いた飛翔害虫防除方法を提供する目的でなされたものである。 The present invention is a chemical volatilization body used by storing a carrier containing a room temperature volatile chemical in a flat drug container and fixing it to a screen door. In addition, a chemical volatilization agent that can be efficiently volatilized and spreads throughout the screen door, and can eliminate or repel flying insect pests such as mosquitoes and flyfish, and a method for controlling flying insects using the same. It is a thing.

本発明は、以下の構成が上記目的を達成するために優れた効果を奏することを見出したものである。すなわち、
(1)常温揮散性薬剤を含有する担体を扁平状の薬剤容器の内部に収納した薬剤揮散体であって、前記薬剤容器の厚みが3mm〜10mmであり、かつ前記担体と前記薬剤容器内面との間に1mm以上の隙間を設けたことを特徴とする網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。
(2)前記薬剤容器の屋外側の開口面積(A)と屋内側の開口面積(B)の比率(A)/(B)が2/1〜1/2であることを特徴とする(1)に記載の網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。
(3)前記常温揮散性薬剤を含有する担体が、ポリオレフィン系樹脂からなる網状構造であり、その線径が0.1〜2mmであることを特徴とする(1)又は(2)に記載の網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。
(4)前記常温揮散性薬剤を含有する網状の担体が、前記薬剤容器内に複数枚収納されることを特徴とする(1)〜(3)の何れかに記載の網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。
(5)前記常温揮散性薬剤が、メトフルトリン、プロフルトリン、エンペントリン及びトランスフルトリンの1種又は2種以上であることを特徴とする(1)〜(4)の何れかにに記載の薬剤揮散体。
(6)前記薬剤揮散体を面ファスナーを用いて網戸に固定することを特徴とする(1)〜(5)の何れかにに記載の飛翔害虫防除方法。
The present invention has been found that the following constitution has an excellent effect for achieving the above-mentioned object. That is,
(1) A drug volatilization body in which a carrier containing a room temperature volatile drug is housed in a flat drug container, wherein the drug container has a thickness of 3 mm to 10 mm, and the carrier, the drug container inner surface, A chemical volatilizer used by being fixed to a screen door, and a method for controlling flying insects using the same, characterized in that a gap of 1 mm or more is provided between them.
(2) The ratio (A) / (B) of the opening area (A) on the outdoor side of the medicine container and the opening area (B) on the indoor side is 2/1 to 1/2 (1) The chemical volatilization body used by being fixed to the screen door described in the above) and a flying insect control method using the same.
(3) The carrier containing the room temperature volatile drug is a network structure composed of a polyolefin resin, and the wire diameter thereof is 0.1 to 2 mm. (1) or (2) A chemical volatilizer fixed to a screen door and a flying insect control method using the same.
(4) A plurality of reticulated carriers containing the room temperature volatile drug are housed in the drug container, and are used by being fixed to the screen door according to any one of (1) to (3) Chemical volatilization body and flying pest control method using the same.
(5) The volatile drug according to any one of (1) to (4), wherein the room temperature volatile drug is one or more of metofluthrin, profluthrin, empentrin, and transfluthrin. .
(6) The method for controlling flying insects according to any one of (1) to (5), wherein the chemical volatilization body is fixed to a screen door using a hook-and-loop fastener.

本発明の薬剤揮散体及びこれを用いた害虫防除方法により、窓や雨戸の邪魔にならず、かつ効率的に蚊、ブユ等の飛翔害虫を駆除又は忌避でき、その実用性は極めて高い。 By the chemical volatilization body of the present invention and the pest control method using the chemical volatilization body, the flying pests such as mosquitoes and flyfish can be controlled or avoided efficiently without interfering with windows and shutters, and its practicality is extremely high.

本発明の薬剤揮散体は網戸に固定して、蚊、ブユ等の飛翔害虫を駆除又は忌避する。薬剤揮散体を網戸に固定する場合、窓や雨戸を開閉する際に邪魔にならないよう薬剤容器は扁平形状にする必要がある。本発明の薬剤揮散体は容器内に収納された担体の表面を空気が流れることにより担体に含有された薬剤が徐々に揮散し効果を発揮する。上記のように扁平形状の場合、担体と容器内面との間に一定の隙間を持たせることにより、その隙間を空気が通過し、担体全体から薬剤が効率よく揮散する。 The chemical volatilization body of the present invention is fixed to a screen door to eliminate or repel flying insects such as mosquitoes and flyfish. When fixing a chemical volatilization body to a screen door, it is necessary to make a chemical | medical agent container into a flat shape so that it may not become obstructive when opening and closing a window and a shutter. In the drug volatilization body of the present invention, when the air flows on the surface of the carrier housed in the container, the drug contained in the carrier is gradually volatilized and exhibits the effect. In the case of a flat shape as described above, by providing a certain gap between the carrier and the inner surface of the container, air passes through the gap and the drug is efficiently vaporized from the entire carrier.

本発明では、薬剤容器の厚みを3mm〜10mmとし、かつ担体と容器内面とのの隙間を1mm以上とすることにより、網戸に固定しても邪魔にならず、かつ、揮散した薬剤が網戸の網目全体に効率よく広がり、効果を発揮することを見出した。容器の厚みが3mm未満の場合、担体と容器内面との隙間が保たれず、担体表面を流れる空気が少なく、揮散効率が悪くなる。逆に10mmを超えても揮散効率にさほど有利とならないばかりか、窓や雨戸を開閉する際、容器が引っかかる可能性が生じる。また、担体と容器内面との隙間については、1mm未満の場合、容器内全体に空気が入り込まず、容器開口部分を空気が通り過ぎるのみとなるため、その部分の薬剤のみが揮散する結果、薬剤の揮散量低下を招き一定期間安定した効果を奏し得ない。従って、コンパクトな容器形状の場合、担体と容器には1mm以上の隙間を確保することが必須要件となる。 In the present invention, the thickness of the drug container is 3 mm to 10 mm, and the gap between the carrier and the container inner surface is 1 mm or more. It was found that it spreads efficiently over the entire mesh and exerts its effect. When the thickness of the container is less than 3 mm, the gap between the carrier and the inner surface of the container is not maintained, and there is less air flowing on the surface of the carrier, resulting in poor volatilization efficiency. Conversely, if it exceeds 10 mm, not only is it not very advantageous for volatilization efficiency, but there is a possibility that the container will get caught when opening and closing windows and shutters. In addition, when the gap between the carrier and the inner surface of the container is less than 1 mm, air does not enter the entire container, and only the air passes through the opening portion of the container. The volatilization amount is reduced and a stable effect cannot be achieved for a certain period. Therefore, in the case of a compact container shape, it is an essential requirement to ensure a gap of 1 mm or more between the carrier and the container.

本発明では、薬剤容器の屋外側の開口面積(A)と屋内側の開口面積(B)の比率(A)/(B)は2/1〜1/2であることが好ましい。
通常、空気の流れは一般的に、容器の屋外側の開口部から流入したのち、容器内を通過、もしくは屋内側の開口部から容器外に流出すると考えられるので、開口部の面積は常温揮散性薬剤の揮散量をコントロールするうえで重要である。容器厚みが小さい場合、空気量が少なく、屋外側と屋内側の開口面積に極端な差が生じると薬剤の揮散量が著しく減少する。
さらに、薬剤容器の屋外側の開口面積(A)と屋内側の開口面積(B)の比率(A)/(B)は1/1〜1/2であることがより好ましい。
In the present invention, the ratio (A) / (B) of the opening area (A) on the outdoor side of the medicine container and the opening area (B) on the indoor side is preferably 2/1 to 1/2.
Normally, the flow of air is generally considered to flow through the inside of the container after flowing from the opening on the outdoor side of the container, or out of the container from the opening on the indoor side. It is important in controlling the volatilization amount of sex medicine. When the container thickness is small, the amount of air is small, and if there is an extreme difference in the opening area between the outdoor side and the indoor side, the volatilization amount of the drug is remarkably reduced.
Furthermore, the ratio (A) / (B) of the opening area (A) on the outdoor side of the medicine container and the opening area (B) on the indoor side is more preferably 1/1 to 1/2.

本発明で用いる薬剤容器の形状は網戸に貼る使用方法であるため、扁平状であることが望ましい。また、その形状は略直方体、略円柱状、略楕円状等が挙げられるがこれらに限定されず、嗜好性に合わせた形状にすることができる。
容器の構造としては、例えば平面シート状の樹脂部材を折り曲げたものが挙げられる。この場合、容器は上記折り曲げた部材の2つを一組として用い、それぞれの部材の折り曲げ面が重なりあうように組み立てられる。また、樹脂の一体成型品を使用することもできる。ここでいう樹脂の一体成型品とは、通常の射出成型又は真空成型で成型したもの等であれば成型方法は問わないが、屋外側と屋内側をヒンジを用いて一体としたり、嵌合したりすることによって一体とすれば、製造工程をより簡略化することができる。
Since the shape of the medicine container used in the present invention is a usage method for attaching to a screen door, it is desirable that the shape is a flat shape. In addition, examples of the shape include a substantially rectangular parallelepiped, a substantially cylindrical shape, and a substantially elliptical shape. However, the shape is not limited to these, and the shape can be adapted to the preference.
As a structure of a container, what bent the planar sheet-like resin member is mentioned, for example. In this case, the container is assembled using two of the folded members as a set, and the folded surfaces of the members are overlapped. Also, an integrally molded product of resin can be used. The resin integrally molded product here may be any molding method as long as it is molded by normal injection molding or vacuum molding, etc., but the outdoor side and the indoor side are integrated using a hinge or fitted. If integrated, the manufacturing process can be further simplified.

これら容器に用いる樹脂の材質としては、ポリエチレンテレフタレート(PET)、ポリエチレン、ポリプロピレン、ポリブチレンテレフタレート(PBT)、ナイロン、ポリアミド等、種々の樹脂材料が使用可能であるが、強度やその性質を考慮すると、ポリエチレンテレフタレート(PET)やポリブチレンテレフタレート(PBT)を用いるのが好ましい。 As resin materials used in these containers, various resin materials such as polyethylene terephthalate (PET), polyethylene, polypropylene, polybutylene terephthalate (PBT), nylon, and polyamide can be used. Polyethylene terephthalate (PET) or polybutylene terephthalate (PBT) is preferably used.

また、これら樹脂の厚みは種々のものが使用可能であるが、樹脂担体の形状やその揮散性能との関係、経済性等の点から、0.05mm〜2mmのものを使用するのが好ましい。 Various thicknesses of these resins can be used, but it is preferable to use those having a thickness of 0.05 mm to 2 mm from the viewpoint of the shape of the resin carrier, its volatilization performance, economy, and the like.

本発明で用いられる担体は、含浸又は練り込みにより揮散性薬剤を保持させたものを用いる。材質としては、紙、繊維、樹脂などのいずれも使用可能であるが、有効成分を練り込んだ樹脂製のものを採用すると、使用期間中の薬剤の徐放性を制御でき安定した薬剤揮散量を実現できること、かつ雨など水分による薬剤の流れ落ちの心配がない点から好ましい。樹脂材質としてはポリエチレン、ポリプロピレン、ポリビニルアルコール、ポリ酢酸ビニル、ポリブタジエン、ポリイソプレン、エチレンーメチルメタクリレート共重合体、スチレンーブタジエン共重合体等のポリオレフィン系樹脂が好ましい。 As the carrier used in the present invention, a carrier in which a volatile chemical is held by impregnation or kneading is used. Paper, fiber, resin, etc. can be used as the material, but if a resin-made material with an active ingredient is used, the sustained release of the drug during the period of use can be controlled and the amount of drug volatilized is stable. It is preferable from the viewpoint that it is possible to realize the above and that there is no worry of the drug flowing down due to moisture such as rain. As the resin material, polyolefin resins such as polyethylene, polypropylene, polyvinyl alcohol, polyvinyl acetate, polybutadiene, polyisoprene, ethylene-methyl methacrylate copolymer, styrene-butadiene copolymer are preferable.

本発明において使用される樹脂担体の形状は、薬剤の揮散効率を考慮し網状形状が好ましい。網の線径としては、同じく揮散効率の点から0.1〜2mmの範囲が好適であるが、薬剤の種類や使用期間に応じて上記範囲内から適宜設定すればよい。すなわち、蒸気圧の高い薬剤の場合には、線径を大きくすることにより揮散を抑制するように調整し、蒸気圧の低い薬剤の場合は、線径を小さくすることによって揮散を促すように調整する。 The shape of the resin carrier used in the present invention is preferably a net shape considering the volatilization efficiency of the drug. The wire diameter of the net is also preferably in the range of 0.1 to 2 mm from the viewpoint of volatilization efficiency, but may be appropriately set from the above range depending on the type of drug and the period of use. In other words, in the case of a drug with a high vapor pressure, adjustment is made to suppress volatilization by increasing the wire diameter, and in the case of a drug with a low vapor pressure, adjustment is made to promote volatilization by reducing the wire diameter. To do.

本発明において使用される薬剤としては、常温において揮散する性質を持つものであり、空気中に揮散するものであれば特に限定されない。より強力な効果を発揮できる点でピレスロイド系薬剤を用いるのが好ましく、なかんずく揮散性能や飛翔害虫に対する基礎活性が高いメトフルトリン、プロフルトリン、エンペントリン及びトランスフルトリンの1種又は2種以上が好適である。 The drug used in the present invention is not particularly limited as long as it has a property of volatilizing at room temperature and volatilizes in the air. It is preferable to use a pyrethroid based on the point that a more powerful effect can be exerted. Among them, one or more of metfurthrin, profluthrin, enpentrin, and transfluthrin, which have high volatility and high basic activity against flying insects, are preferable.

本発明では、薬剤を含有した担体を薬剤容器に複数枚重ねて収納することができる。担体を複数枚にすることにより、薬剤揮散面積が増え、その分、薬剤の単位時間当たりの揮散量を増やすことが可能となる。また、複数枚の担体毎に薬剤の種類や濃度、網の線径を変え、各薬剤の特長を生かした製剤とすることもできる。 In the present invention, a plurality of carriers containing a drug can be stacked and stored in a drug container. By using a plurality of carriers, the chemical volatilization area increases, and the amount of chemical volatilization per unit time can be increased accordingly. In addition, by changing the type and concentration of the drug and the wire diameter of the net for each of a plurality of carriers, it is possible to obtain a preparation that takes advantage of the characteristics of each drug.

担体に保持される常温揮散性の薬剤の配合量は使用する薬剤の種類により異なるが、効果を発揮する有効成分量の確保、樹脂に薬剤を練り込んだ後の成型性、更に、担体表面に薬剤がブリードしてべたつきを起こすことを防止する点から2〜12重量%の範囲とすることが好ましい。すなわち、薬剤の配合量が2重量%未満の場合には、効果を発揮する有効成分量が確保することが困難となる。一方、12重量%を超えると、網目状の成型が困難となり、更に、網表面に薬剤が多量にブリードしてべたつきを起こしやすくなる。 The blending amount of the room temperature volatile drug held on the carrier varies depending on the type of drug used, but the amount of active ingredient that exhibits the effect is ensured, the moldability after kneading the drug into the resin, and the carrier surface From the viewpoint of preventing the drug from bleeding and causing stickiness, the content is preferably in the range of 2 to 12% by weight. That is, when the compounding amount of the drug is less than 2% by weight, it is difficult to ensure an effective ingredient amount that exhibits the effect. On the other hand, when the content exceeds 12% by weight, it is difficult to form a mesh, and the drug tends to bleed on the surface of the mesh and cause stickiness.

なお、本発明で用いる薬剤には、共力剤、忌避剤、抗菌剤、防黴剤、芳香剤等も同時に使用可能であり、例えば、共力剤としては、オクタクロロジプロピルエーテル(商品名S−421)、イソボルニルチオシアノアセテート(商品名IBTA)、N−オクチルビシクロヘプテンカルボキシイミド(商品名サイネピリン222)、N−(2−エチルヘキシル)−1−イソプロピル−4−メチルビシクロ[2,2,2]オクト−5−エン−2,3−ジカルボキシイミド(商品名サイネピリン500)が挙げられる。忌避剤としては、N,N−ジエチル−m−トルアミド(商品名ディート)、ジメチルフタレート、ジブチルフタレート、2−エチル−1,3−ヘキサンジオール、1,4,4a,5a,6,9,9a,9b−オクタヒドロジベンゾフラン−4a−カルバイド、p−メンタン−3,8−ジオール等が挙げられる。
抗菌剤としては、ヒノキチオール、テトラヒドロリナロール、オイゲノール、シトロネラール、アリルイソチオシアネート等が挙げられる。
防黴剤としては、イソプロピルメチルフェノール、オルトフェニルフェノール等が挙げられる。
芳香剤としては、シトロネラ油、オレンジ油、レモン油、ライム油、ユズ油、ラベンダー油、ペパーミント油、ユーカリ油、ジャスミン油、ヒノキ油、緑茶精油、リモネン、α―ピネン、リナロール、ゲラニオール、フェニルエチルアルコール、アミルシンナミックアルデヒド、クミンアルデヒド、ベンジルアセテート等が挙げられる。
更に、香料、着色剤、帯電防止剤等を適宜配合してもよい。
また、本発明で用いる薬剤はいずれも十分な安定性を有しているが、更に安定性を高めるため、酸化防止剤等の安定剤を添加することも可能であり、例えば2,2’−メチレンビス(4−エチル−6−t−ブチルフェノール)、4,4’−メチレンビス(2−メチル−6−t−ブチルフェノール)、BHT、BHA、メルカプトベンズイミダゾール等を用いることができる。
更に、紫外線吸収阻害剤としてパラアミノ安息香酸類、桂皮酸類、サリチル酸類、ベンゾフェノン類及びベンゾトリアゾール類等の紫外線吸収剤を用いることにより、保管時や使用時の耐光性を一段と向上させることができる。
In addition, synergists, repellents, antibacterial agents, antifungal agents, fragrances and the like can be used at the same time for the drugs used in the present invention. For example, as synergists, octachlorodipropyl ether (trade name) S-421), isobornyl thiocyanoacetate (trade name IBTA), N-octylbicycloheptenecarboximide (trade name Sinepilin 222), N- (2-ethylhexyl) -1-isopropyl-4-methylbicyclo [2 , 2, 2] octo-5-ene-2,3-dicarboximide (trade name Sinepirine 500). As repellents, N, N-diethyl-m-toluamide (trade name Diet), dimethyl phthalate, dibutyl phthalate, 2-ethyl-1,3-hexanediol, 1,4,4a, 5a, 6,9,9a , 9b-octahydrodibenzofuran-4a-carbide, p-menthane-3,8-diol, and the like.
Antibacterial agents include hinokitiol, tetrahydrolinalol, eugenol, citronellal, allyl isothiocyanate, and the like.
Examples of the antifungal agent include isopropylmethylphenol and orthophenylphenol.
Air fresheners include citronella oil, orange oil, lemon oil, lime oil, yuzu oil, lavender oil, peppermint oil, eucalyptus oil, jasmine oil, hinoki oil, green tea essential oil, limonene, α-pinene, linalool, geraniol, phenylethyl Examples include alcohol, amylcinnamic aldehyde, cuminaldehyde, and benzyl acetate.
Furthermore, you may mix | blend a fragrance | flavor, a coloring agent, an antistatic agent, etc. suitably.
Moreover, although all the chemical | medical agents used by this invention have sufficient stability, in order to raise stability further, it is also possible to add stabilizers, such as antioxidant, for example, 2,2'-. Methylene bis (4-ethyl-6-tert-butylphenol), 4,4′-methylene bis (2-methyl-6-tert-butylphenol), BHT, BHA, mercaptobenzimidazole and the like can be used.
Furthermore, by using ultraviolet absorbers such as paraaminobenzoic acids, cinnamic acids, salicylic acids, benzophenones and benzotriazoles as ultraviolet absorption inhibitors, the light resistance during storage and use can be further improved.

本発明において薬剤容器を網戸に固定する方法としては、面ファスナーやフック、粘着テープ、粘着ゲル等が使用可能であるが、網戸の細かい網目に固定すること、また優れた耐雨性や耐光性が要求されることを考慮した場合、面ファスナーを用いて確実に固定することが好ましい。固定具の容器への設置位置については、複数箇所への設置が好ましいが、1箇所固定の場合でも製剤の外観を損なわない範囲でできる限り大きくすればよい。そして、網戸の屋外側に本発明の薬剤容器を取り付けたのち、網戸の屋内側から面ファスナーを用いて固定すると便利である。 In the present invention, as a method for fixing the drug container to the screen door, a hook-and-loop fastener, a hook, an adhesive tape, an adhesive gel, and the like can be used, but fixing to the fine screen of the screen door and excellent rain resistance and light resistance are also possible. In consideration of what is required, it is preferable to securely fix the surface fastener using a hook-and-loop fastener. About the installation position to the container of a fixing tool, although installation to multiple places is preferable, what is necessary is just to enlarge as much as possible in the range which does not impair the external appearance of a formulation even in the case of 1 place fixation. And after attaching the chemical | medical agent container of this invention to the outdoor side of a screen door, it is convenient to fix using the hook-and-loop fastener from the indoor side of a screen door.

次に、本発明の試験例について説明するが、本発明はこれらの試験例のみに限定されるものではない。 Next, although the test example of this invention is demonstrated, this invention is not limited only to these test examples.

透明のポリエチレンテレフタレート(PET)製の略直方体状の薬剤容器(長さ115mm、幅65mm、厚み5mm)に、メトフルトリン100mgを含有する樹脂製網状担体(長さ110mm、幅60mm)を収納した。担体と薬剤容器の内面との隙間は2mmであり、薬剤容器の屋外側と屋内側の開口比率は1/1であった。 A resin net carrier (length: 110 mm, width: 60 mm) containing 100 mg of metfurthrin was accommodated in a substantially rectangular parallelepiped drug container (length: 115 mm, width: 65 mm, thickness: 5 mm) made of transparent polyethylene terephthalate (PET). The gap between the carrier and the inner surface of the drug container was 2 mm, and the opening ratio between the outdoor side and the indoor side of the drug container was 1/1.

(効力試験)
100m3の部屋(室温25℃)の一角に18メッシュの網戸(長さ190cm、幅90cm)を設置した小部屋を作った。この小部屋内にボランティア1名が入り、網戸から5m離れた位置からアカイエカ50匹を放ち、網戸に止まったアカイエカの数を計数し、下記式により付着防止率を算出した。
付着防止率(%)
=(無処理区の付着数―処理区の付着数)/無処理区の付着数×100
<評価>
◎:付着防止率が80%以上
○:付着防止率が60%以上〜80%未満
△:付着防止率が40%以上〜60%未満
×:付着防止率が40%未満
(Efficacy test)
A small room was created with an 18-mesh screen (length 190 cm, width 90 cm) in one corner of a 100 m 3 room (room temperature 25 ° C.). One volunteer entered this small room, 50 squid were released from a position 5 m away from the screen, the number of squid was stopped on the screen, and the adhesion prevention rate was calculated by the following formula.
Adhesion prevention rate (%)
= (Number of deposits in untreated section-Number of deposits in treated section) / Number of deposits in untreated section × 100
<Evaluation>
◎: Adhesion prevention rate is 80% or more ○: Adhesion prevention rate is 60% or more to less than 80% △: Adhesion prevention rate is 40% or more to less than 60% ×: Adhesion prevention rate is less than 40%

実施例1に準じて表1に示す薬剤担体及び薬剤容器を用いて評価した。 According to Example 1, the evaluation was performed using the drug carrier and drug container shown in Table 1.

試験の結果、常温揮散性薬剤を含有する担体を扁平状の厚み3mm〜10mmの薬剤容器に収納した薬剤揮散体で、担体と容器内面との隙間を1mm以上とした場合、一定期間、飛翔害虫を寄せ付けない優れた効果が認められた。
これに対し、比較例1のように、薬剤容器の厚みが3mm未満で、担体と容器の隙間を1mm未満となして密着させた場合、容器内に空気が入りにくく忌避効果が低減した。また、比較例2では、薬剤容器の厚みを12mmとし、容器の屋外側と屋内側の開口比率を1/3としたころ、窓の開閉の際に邪魔となり、また、容器内の空気の流れが非効率で忌避効果が持続しない状況となった。更に比較例3、4では、容器厚みはそれぞれ8mm,5mmであり、空気が入りやすい状況であったが、担体を重ねて厚くしたため担体と容器内面の隙間が1mm未満となった。このため、容器内で空気の流れが生起せず、初期では効果が認められたものの、その後効力は低減した。
As a result of the test, when the carrier containing the room temperature volatile drug is stored in a flat drug container having a thickness of 3 mm to 10 mm and the gap between the carrier and the container inner surface is 1 mm or more, the flying insects for a certain period of time. An excellent effect was observed that was not able to keep up.
On the other hand, when the thickness of the drug container was less than 3 mm and the gap between the carrier and the container was less than 1 mm as in Comparative Example 1, it was difficult for air to enter the container and the repelling effect was reduced. In Comparative Example 2, when the thickness of the drug container is 12 mm and the opening ratio between the outdoor side and the indoor side of the container is 1/3, it becomes an obstacle when opening and closing the window, and the air flow in the container However, it became inefficient and the repellent effect did not last. Further, in Comparative Examples 3 and 4, the thicknesses of the containers were 8 mm and 5 mm, respectively, and it was easy for air to enter. However, since the thickness of the carriers was increased, the gap between the carrier and the inner surface of the container was less than 1 mm. For this reason, the flow of air did not occur in the container, and although the effect was recognized in the initial stage, the efficacy was reduced thereafter.

本発明は、網戸に固定して蚊、ブユ等の飛翔害虫を駆除又は忌避するための薬剤揮散体及びこれを用いた防虫方法を提供するもので害虫を駆除又は忌避する分野に適している。 INDUSTRIAL APPLICABILITY The present invention provides a chemical volatilizer for fixing or repelling flying insect pests such as mosquitoes and flyfish by fixing to a screen door, and an insect repellent method using the same, and is suitable for the field of controlling or repelling insect pests.

Claims (6)

常温揮散性薬剤を含有する担体を扁平状の薬剤容器の内部に収納した薬剤揮散体であって、前記薬剤容器の厚みが3mm〜10mmであり、かつ前記担体と前記薬剤容器内面との間に1mm以上の隙間を設けたことを特徴とする網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。 A drug volatilizer containing a carrier containing a room temperature volatile drug in a flat drug container, the drug container having a thickness of 3 mm to 10 mm, and between the carrier and the drug container inner surface A chemical volatilization body used by being fixed to a screen door provided with a gap of 1 mm or more, and a flying insect control method using the same. 前記薬剤容器の屋外側の開口面積(A)と屋内側の開口面積(B)の比率(A)/(B)が2/1〜1/2であることを特徴とする網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。 The ratio (A) / (B) of the opening area (A) on the outdoor side of the medicine container and the opening area (B) on the indoor side is 2/1 to 1/2. A chemical volatilizer to be used and a method for controlling flying insects using the same. 前記常温揮散性薬剤を含有する担体がポリオレフィン系樹脂からなる網状構造であり、その線径が0.1〜2mmであることを特徴とする請求項1又は2に記載の網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。 The carrier containing the room-temperature volatile drug is a network structure made of a polyolefin resin, and the wire diameter thereof is 0.1 to 2 mm, which is used by being fixed to the screen door according to claim 1 or 2. Chemical volatilization body and flying pest control method using the same. 前記常温揮散性薬剤を含有する網状の担体が、前記薬剤容器内に複数枚収納されることを特徴とする請求項1〜3の何れかに記載の網戸に固定して用いる薬剤揮散体及びこれを用いた飛翔害虫防除方法。 The drug volatilizer used by being fixed to a screen door according to any one of claims 1 to 3, wherein a plurality of reticulated carriers containing the room temperature volatile drug are accommodated in the drug container. Flying pest control method using 前記常温揮散性薬剤がメトフルトリン、プロフルトリン、エンペントリン及びトランスフルトリンの1種又は2種以上であることを特徴とする請求項1〜4の何れかに記載の薬剤揮散体。 The drug volatilizer according to any one of claims 1 to 4, wherein the room temperature volatile drug is one or more of metofluthrin, profluthrin, empentrin, and transfluthrin. 前記薬剤揮散体を面ファスナーを用いて網戸に固定することを特徴とする請求項1〜5の何れかに記載の飛翔害虫防除方法。 The method for controlling flying insects according to any one of claims 1 to 5, wherein the chemical volatilization body is fixed to a screen door using a hook-and-loop fastener.
JP2011000910A 2011-01-06 2011-01-06 Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same Pending JP2012140384A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011000910A JP2012140384A (en) 2011-01-06 2011-01-06 Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011000910A JP2012140384A (en) 2011-01-06 2011-01-06 Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same

Publications (1)

Publication Number Publication Date
JP2012140384A true JP2012140384A (en) 2012-07-26

Family

ID=46677065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011000910A Pending JP2012140384A (en) 2011-01-06 2011-01-06 Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same

Country Status (1)

Country Link
JP (1) JP2012140384A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014065150A1 (en) * 2012-10-22 2014-05-01 大日本除蟲菊株式会社 Chemical volatilization body
JP7485555B2 (en) 2020-06-25 2024-05-16 大日本除蟲菊株式会社 Flying insect pest control drug volatilizer and flying insect pest control method using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001200239A (en) * 2000-01-17 2001-07-24 Earth Chem Corp Ltd Chemical agent holding body for chemical agent vaporization and chemical agent vaporization method
WO2010058817A1 (en) * 2008-11-19 2010-05-27 アース製薬株式会社 Transpiration material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001200239A (en) * 2000-01-17 2001-07-24 Earth Chem Corp Ltd Chemical agent holding body for chemical agent vaporization and chemical agent vaporization method
WO2010058817A1 (en) * 2008-11-19 2010-05-27 アース製薬株式会社 Transpiration material

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN7014003145; 意匠公報 , 20080929 *
JPN7014003146; トピックス&ニュース , 20080301, [平成26年10月27日検索] *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014065150A1 (en) * 2012-10-22 2014-05-01 大日本除蟲菊株式会社 Chemical volatilization body
CN104735978A (en) * 2012-10-22 2015-06-24 大日本除虫菊株式会社 Chemical volatilization body
JPWO2014065150A1 (en) * 2012-10-22 2016-09-08 大日本除蟲菊株式会社 Drug volatilizer
AU2013335918B2 (en) * 2012-10-22 2016-11-17 Dainihon Jochugiku Co., Ltd. Chemical volatilization body
JP7485555B2 (en) 2020-06-25 2024-05-16 大日本除蟲菊株式会社 Flying insect pest control drug volatilizer and flying insect pest control method using the same

Similar Documents

Publication Publication Date Title
JP6408091B2 (en) Drug volatilizer
JP7324887B2 (en) Mosquito control aerosol and mosquito control method
JP5137591B2 (en) Drug volatilizer
KR101933934B1 (en) Device and method for vaporizing/discharging chemical agent
JP5556790B2 (en) Composition in which light / ultraviolet light deterioration of pyrethroid compound is prevented and method for preventing light / ultraviolet light deterioration
JP2012140384A (en) Drug sublimating body using by fixing to screen door and method for repelling flying harmful insect using the same
JP2017186275A (en) Insecticidal film and method for producing insecticidal film
JP2010090048A (en) Drug vaporizer
JP5805521B2 (en) Chemical agent for doorknob
JP5553503B2 (en) Chemical volatilization body and insect control method using chemical volatilization body
JP7485555B2 (en) Flying insect pest control drug volatilizer and flying insect pest control method using the same
JP2004254550A (en) Agent storage
JP5948010B2 (en) Chemical vaporizer to prevent cockroach invasion
JP5754895B2 (en) Chemical volatilization device
WO2020166709A1 (en) Chemical volatilizing device
JP2016042859A (en) Volatile substance storing container
JP2017023096A (en) Three-dimensional chemical volatilizer
JP2012034597A (en) Chemical volatilization apparatus
JP6644516B2 (en) Fan-type volatile chemical vaporizer
JP2016054653A (en) Chemical volatilization device
JP5328282B2 (en) Drug carrier for air cleaner installation
JP6228578B2 (en) Drug container
JP2005126393A (en) Aroma-releasing and insect-proofing product
JP2016123390A (en) Three-dimensional structure containing volatile chemical
JP2018038277A (en) Chemical volatilization body and volatilization method

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141118

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150217